๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial

โœ Scribed by Korevaar, Johanna C.; Feith, G.W.; Dekker, Friedo W.; van Manen, Jeannette G.; Boeschoten, Elisabeth W.; Bossuyt, Patrick M.M.; Krediet, Raymond T.; for The Necosad Study Group,

Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
89 KB
Volume
64
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Randomized trial of darbepoetin alfa for
Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients
โœ Vanrenterghem, Yves; Bรƒยกrรƒยกny, Peter; Mann, Johannes F.E.; Kerr, Peter G.; Wilso ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 601 KB

## Background: Darbepoetin alfa is a glycoprotein with a three-fold longer terminal half-life than recombinant human erythropoietin (rhuepo). we aimed to determine whether darbepoetin alfa is as effective and well tolerated as rhuepo for treating renal anemia in dialysis patients when administered

Cabergoline compared to levodopa in the
Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial
โœ Claudia Trenkwalder; Heike Benes; Ludger Grote; Svenja Happe; Birgit Hรถgl; Johan ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 128 KB ๐Ÿ‘ 1 views

## Abstract We report the first largeโ€scale doubleโ€blind, randomly assigned study to compare two active dopaminergic therapies for Restless Legs Syndrome (RLS), the dopamine agonist cabergoline (CAB) and levodopa/benserazide (levodopa). Patients with idiopathic RLS were treated with fixed daily dos

Effect of botulinum toxin type A on qual
Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial
โœ M.K. Naumann; H. Hamm; N.J. Lowe; ON BEHALF OF THE BOTOXยฎ HYPERHIDROSIS CLINICAL ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB

## Background: Botulinum toxin type a (btx-a) has been shown to be a safe and effective treatment for primary focal hyperhidrosis. however, the effect of btx-a therapy on quality of life (qol) in patients with this condition has only recently begun to be studied in controlled clinical trials. ## O

Effects of interferon treatment on devel
Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: A meta-analysis of randomized controlled trials
โœ Chuan-Hai Zhang; Ge-Liang Xu; Wei-Dong Jia; Jian-Sheng Li; Jin-Liang Ma; Yong-Sh ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 311 KB ๐Ÿ‘ 2 views

## Abstract Available literature on the effects of interferon (IFN) treatment on development and progression of hepatocellular carcinoma (HCC) in patients with chronic virus infection reports controversial results. The primary objective of this metaโ€analysis was to evaluate the effect of IFN on HCC